Previous studies have shown that overexpression of human ApoA1 in the circulation can prevent learning and memory impairment in APP/PS1 transgenic mice, partly by reducing neuroinflammation and cerebral amyloid angiopathy [41]. This evidence concerns the gene APP and cerebral amyloid angiopathy.